查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2109022

防沾黏材料：市場趨勢、競爭格局和市場預測 - 2034 年

Adhesion Barrier - Market Insights, Competitive Landscape, and Market Forecast - 2034
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

概述：

  • 全球防黏材料市場預計到 2025 年將達到 11 億美元，到 2034 年將達到 20 億美元。
  • 預計在 2026 年至 2034 年的預測期內，該市場將以 6.9% 的複合年成長率成長。這一成長的促進因素包括：腹部、骨盆、婦科和脊柱手術數量的增加，外科醫生和患者對粘連相關併發症的認知不斷提高，透明質酸和合成聚合物屏障技術相關臨床證據的積累，以及結合止血和防粘連功能的多功能產品的推出。
  • 按產品類型分類，薄膜和膜阻隔層預計將引領防黏連阻隔層市場，到 2025 年將佔 39% 的市場佔有率。
  • 按材料分類，預計到 2025 年，透明質酸和纖維素基屏障材料將佔 44% 的市場佔有率，引領防沾黏屏障市場。
  • 按應用領域分類，預計到 2025 年，婦科手術領域將佔 34% 的市場佔有率，引領沾黏預防屏障市場。
  • 按最終用戶分類，預計醫院領域將引領黏連預防屏障市場，到 2025 年將佔據 71% 的市場佔有率。
  • 截至 2025 年，北美在防黏材料市場中佔據最大佔有率，為 41%，但預計到 2034 年，亞太地區將實現最快成長。

沾黏預防材料是手術期間應用的醫療設備，用於在癒合期間分離受損組織表面，減少術後沾黏的發生率、範圍和嚴重程度。術後沾黏是指手術後在器官和組織之間形成的纖維疤痕組織帶。此系列產品包括透明質酸和羧甲基纖維素 (HA/CMC) 薄膜，例如 Baxter 的 Seprafilm；氧化再生纖維素屏障，例如 Johnson & Johnson MedTech 的 Interceed 和 Intercoat；基於艾考糊精的減少粘連溶液，例如 Baxter 的 Adept；二元聚合物（羧甲基纖維素/聚環糊精的減少粘連溶液，例如 Baxter 的 Adept；二元聚合物（羧甲基纖維素/聚環噴霧）系列；以膠原蛋白的硬腦膜粘連預防基質，例如 Integra LifeSciences 的 DuraGen Plus；透明質酸凝膠，例如 Anika Therapeutics 開發並由 Nordic Pharma 銷售的 Hyalobarrier；澱粉基粉末和凝膠屏障，例如 PlantTecurge 的 4DryField PH；以及用於心血管手術的生物可吸收薄膜的膠原蛋白；以及用於心血管手術的生物可吸收薄膜的 CASTm 和 Bioovam； CardioWrap。該市場涵蓋婦科、一般外科和腹部外科、整形外科和脊椎外科、心血管外科、神經外科和泌尿系統等領域的應用。

抗黏附材料市場的主要成長促進因素

  • 全球腹部、骨盆腔、婦科和脊椎手術數量的不斷增加，為術中沾黏預防提供了巨大的需求基礎。
  • 外科醫師和患者越來越意識到併發症相關併發症（如腸阻塞、慢性骨盆疼痛和不孕症）的發生率、成本和發病率。
  • 使用透明質酸、纖維素和合成聚合物的屏障技術在臨床上的證據日益增多，推動了臨床指南和醫院採購決策中對這些技術的採用。
  • 集止血和防粘連於一體的多功能產品的推出，簡化了手術流程。
  • 腹部和骨盆腔手術的翻修和矯正手術發生率不斷增加，導致越來越多的患者面臨沾黏相關併發症的高風險。
  • 微創和腹腔鏡手術技術的日益普及，擴大了凝膠和噴霧型屏障劑的應用範圍。
  • 醫院和門診手術中心正在增加對外科手術支援產品的投入，以降低再入院率和再次手術率，並支持以價值為導向的醫療保健目標。

推動防黏材料市場成長的因素

市場促進因素

腹部、骨盆腔、婦科和脊椎手術數量增加。

推動防沾連材料市場發展的根本動力是全球腹部、骨盆、婦科和脊椎手術數量的持續成長。所有這些手術都存在術後沾黏形成的風險。根據百特等製造商引用的研究顯示，高達93%的接受開放性手術的患者會出現粘連，據估計，僅在美國，與粘連相關的併發症每年就造成超過20億美元的損失。隨著人口老化和婦科及大腸直腸疾病盛行率的上升，子宮切除術、肌瘤切除術、腸切除術、剖腹產和腰椎切除術的數量也在增加，因此，符合輔助防沾黏材料使用條件的患者群體也在相應擴大。外科醫生擴大將防粘連材料作為高風險手術的常規輔助手段，尤其是在腹部和骨盆手術的翻修手術中，預計這將使防粘連材料產品在整個預測期內保持需求。

人們越來越意識到與粘連相關的併發症和費用

外科醫生和醫療系統對術後沾黏帶來的臨床和經濟負擔的認知不斷提高，是推動沾黏預防材料應用的重要動力。沾黏是小腸腸阻塞、慢性骨盆腔疼痛和續發性不孕症的主要原因，並顯著增加再次手術的複雜性、持續時間和併發症風險。儘管沾黏會帶來這些負擔，但已發表的研究表明，只有一小部分接受腹部和骨盆手術的患者了解粘連的風險和預防措施，這意味著隨著人們認知的提高，粘連預防材料的應用仍有很大的提升空間。隨著醫院和外科醫生越來越意識到粘連導致的再次入院和再次手術所帶來的間接成本，預計粘連預防材料作為高風險手術的輔助預防手段的應用將會擴大，並且預計在預測期內需求將保持穩定。

市場限制因素

沾黏預防屏障市場面臨許多相互關聯的限制因素，阻礙其發展。其中最主要的因素是，不同屏障技術在實際應用中降低臨床上重要的沾黏相關併發症（例如再次手術和腸阻塞）方面，臨床證據不一致，有時甚至相互矛盾。這限制了指南建議的效力，也影響了部分市場的保險報銷支持。產品本身的安全隱患，例如某些薄膜屏障可能引起發炎反應，以及在血液或體液存在下有效性降低等，使得患者選擇和手術技術選擇必須格外謹慎，這可能會限制其在污染或出血手術區域的使用。此外，與標準手術技術相比，薄膜、凝膠和噴霧型屏障產品的成本相對較高，這限制了其在成本敏感且資源有限的醫療機構中的應用。目前，僅有少數接受腹部和骨盆手術的患者了解沾黏的風險和預防措施，這反映出防沾黏材料的使用尚未被常規納入標準手術流程。監管和保險報銷機制因地區和產品類型而異，新適應症（例如Fziomed於2025年獲批用於緩解腰椎疼痛）的保險覆蓋範圍需要時間才能轉化為廣泛的臨床應用。這些因素共同減緩了產品推廣的速度，因此，供應商需要證明其產品具有持續的、針對特定手術的臨床療效和良好的衛生經濟效益，以維持成長。

目錄

第1章：防黏材料市場：簡介

  • 調查範圍
  • 市場區隔
  • 市場概覽

第2章：防黏材料市場：執行摘要

  • 主要亮點和市場概覽

第3章：防黏材料市場：關鍵因素分析

  • 市場促進因素
    • 腹部、骨盆腔、婦科和脊椎手術數量增加。
    • 人們越來越意識到沾黏帶來的發病率和相關費用。
    • 各種屏障技術的臨床證據積累
    • 多功能止血防沾黏產品
  • 市場限制因素
    • 臨床證據不一致以及產品特定的安全考慮
    • 與標準外科手術技術相比，單位成本更高。
    • 標準手術流程的常規應用受到限制。
  • 市場機遇
    • 腹腔鏡和微創手術的輸送。
    • 每項手術的適應症均已擴大。

第4章：人工智慧、地緣政治、貿易與經濟趨勢

第5章：監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第6章：波特五力分析

第7章：防黏材料市場：評估

  • 依產品類型
    • 薄膜和膜屏障
    • 凝膠屏障
    • 溶液和液體屏障
    • 粉末和噴霧型屏障
  • 材料
    • 透明質酸和纖維素基屏障
    • 合成聚合物屏障
    • 膠原膠原蛋白屏障
    • 澱粉和多醣基阻隔材料
  • 透過使用
    • 婦科手術
    • 普通外科和腹部外科
    • 整形外科及脊椎手術
    • 心血管外科
    • 神經外科
    • 泌尿外科泌尿系統
    • 其他
  • 最終用戶
    • 醫院
    • 門診手術中心
    • 專科診所
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 世界其他地區

第8章：防黏材料市場：競爭格局

  • 競爭分析
  • 企業市場占有率分析（加值服務）

第9章：防黏材料市場：新創企業資金籌措與投資趨勢

第10章：防黏材料市場：公司概況與產品概況

  • Baxter International Inc.
  • Fziomed, Inc.
  • Integra LifeSciences Holdings Corporation
  • Medical Devices Business Services, Inc.（Johnson & Johnson MedTech）
  • Anika Therapeutics, Inc.
  • PlantTec Medical GmbH
  • Biom'Up SA
  • MAST Biosurgery USA, Inc.
  • Nordic Pharma
  • Actamax Surgical Materials, LLC

第11章：KOL的觀點

第12章：專案式教學方法

第13章：關於 DelveInsight

第14章 免責聲明與聯絡方式

Product Code: DIMDCL0966

Adhesion Barrier Market Summary

Overview:

  • The global adhesion barrier market was valued at USD 1.1 billion in 2025 and is projected to reach USD 2.0 billion by 2034.
  • The market is expected to expand at a CAGR of 6.9% during the forecast period 2026-2034, supported by the rising volume of abdominal, pelvic, gynecological, and spine surgeries, growing surgeon and patient awareness of adhesion-related complications, the expanding clinical evidence base for hyaluronic acid and synthetic polymer barrier technologies, and the introduction of multifunctional products that combine hemostasis with adhesion prevention.
  • By product type, the film and membrane barriers segment dominated the adhesion barrier market with a 39% share in 2025.
  • By material, the hyaluronic acid and cellulose-based barriers segment dominated the adhesion barrier market with a 44% share in 2025.
  • By application, the gynecological surgery segment dominated the adhesion barrier market with a 34% share in 2025.
  • By end-user, the hospitals segment dominated the adhesion barrier market with a 71% share in 2025.
  • North America accounted for the largest share of the adhesion barrier market at 41% in 2025, while Asia-Pacific is anticipated to register the fastest growth through 2034.

Adhesion barriers are medical devices applied intraoperatively to separate injured tissue surfaces during the healing period and reduce the incidence, extent, and severity of postoperative adhesions, the fibrous bands of scar tissue that form between organs and tissues following surgery. The scope encompasses hyaluronic acid and carboxymethylcellulose (HA/CMC) films such as Seprafilm from Baxter, oxidized regenerated cellulose barriers such as Interceed and Intercoat from Johnson & Johnson MedTech, icodextrin adhesion reduction solution such as Adept from Baxter, dual-polymer carboxymethylcellulose-polyethylene oxide gels and sprays such as the Oxiplex and SprayShield family from Fziomed, collagen-based dural adhesion barrier matrices such as DuraGen Plus from Integra LifeSciences, hyaluronic acid gels such as Hyalobarrier from Anika Therapeutics and distributed by Nordic Pharma, starch-based powder and gel barriers such as 4DryField PH from PlantTec Medical, and bioresorbable synthetic and collagen films for cardiovascular surgery such as Cova CARD from Biom'Up and CardioWrap from MAST Biosurgery. The market spans applications in gynecological, general and abdominal, orthopedic and spine, cardiovascular, neurological, and urological surgery.

Adhesion Barrier Market Key Growth Drivers

  • Rising global volume of abdominal, pelvic, gynecological, and spine surgeries that create the primary demand base for intraoperative adhesion prevention.
  • Growing surgeon and patient awareness of the incidence, cost, and morbidity of adhesion-related complications, including bowel obstruction, chronic pelvic pain, and infertility.
  • Expanding clinical evidence base for hyaluronic acid, cellulose, and synthetic polymer barrier technologies that supports guideline inclusion and hospital purchasing decisions.
  • Introduction of multifunctional products that combine hemostasis and adhesion prevention in a single application, simplifying surgical workflow.
  • Rising incidence of repeat and revision abdominal and pelvic surgery, which increases the population of patients at elevated risk of adhesion-related morbidity.
  • Increasing adoption of minimally invasive and laparoscopic surgical techniques that expand the addressable procedure base for gel and spray-format barriers.
  • Growing hospital and ambulatory surgical center investment in surgical adjuncts that reduce readmission and reoperation rates and support value-based care objectives.

Key Companies in Adhesion Barrier Market

The leading participants in the adhesion barrier market include the following:

  • Baxter International Inc.
  • Fziomed, Inc.
  • Integra LifeSciences Holdings Corporation
  • Medical Devices Business Services, Inc. (Johnson & Johnson MedTech)
  • Anika Therapeutics, Inc.
  • PlantTec Medical GmbH
  • Biom'Up SA
  • MAST Biosurgery USA, Inc.
  • Nordic Pharma
  • Actamax Surgical Materials, LLC

Factors Contributing to the Growth of the Adhesion Barrier Market

Market Drivers

Rising Volume of Abdominal, Pelvic, Gynecological, and Spine Surgeries

The foundational driver of the adhesion barrier market is the sustained global growth in the volume of abdominal, pelvic, gynecological, and spine surgical procedures, each of which carries a meaningful risk of postoperative adhesion formation. Studies cited by manufacturers including Baxter indicate that up to 93% of patients develop adhesions following laparotomy, and adhesion-related complications drive an estimated USD 2 billion or more in annual surgical costs in the United States alone. As the volume of hysterectomy, myomectomy, bowel resection, cesarean section, and lumbar spine procedures grows with the aging population and the rising prevalence of gynecological and colorectal conditions, the population of patients eligible for adjunctive adhesion barrier use expands correspondingly. Surgeons increasingly incorporate adhesion barriers as a routine adjunct in high-risk procedures, particularly repeat abdominal and pelvic surgery, sustaining demand for adhesion barrier products across the forecast period.

Growing Awareness of Adhesion-Related Morbidity and Cost

Growing surgeon and health system awareness of the clinical and economic burden of postoperative adhesions is a powerful driver of adhesion barrier adoption. Adhesions are a leading cause of small bowel obstruction, chronic pelvic pain, and secondary infertility, and they substantially increase the complexity, duration, and risk of complications in reoperative surgery. Despite this burden, publicly cited studies indicate that only a minority of patients undergoing abdominopelvic surgery are counseled about adhesion risk or prevention options, indicating substantial headroom for adoption as awareness grows. As hospitals and surgeons increasingly recognize the downstream cost of adhesion-related readmission and reoperation, the use of adhesion barriers as a preventive adjunct in high-risk procedures is expected to expand, sustaining demand across the forecast period.

Market Restraints

The adhesion barrier market faces several interrelated restraints that temper its growth. The foremost is the inconsistent and, in some cases, contradictory clinical evidence across barrier technologies regarding real-world reduction in clinically meaningful adhesion-related outcomes such as reoperation and bowel obstruction, which limits the strength of guideline recommendations and reimbursement support in several markets. Product-specific safety considerations, including reports of inflammatory response associated with certain film barriers and reduced efficacy in the presence of blood or body fluid, require careful patient selection and surgical technique and can limit use in contaminated or bleeding surgical fields. The relatively high per-unit cost of film, gel, and spray barrier products relative to standard surgical technique constrains adoption in cost-sensitive and lower-resource healthcare settings. Only a minority of eligible abdominopelvic surgery patients are currently counseled about adhesion risk and prevention options, reflecting limited routine integration of adhesion barrier use into standard surgical protocols. Regulatory and reimbursement pathways vary considerably by geography and by product category, and coverage determinations for newer indications, such as Fziomed's 2025 authorization for lumbar spine pain reduction, will take time to translate into broad clinical uptake. Together, these factors moderate the pace of adoption and require vendors to demonstrate consistent, procedure-specific clinical benefit and favorable health-economic outcomes to sustain growth.

Adhesion Barrier Market Segment Analysis

The global adhesion barrier market is segmented by product type (film and membrane barriers, gel barriers, solution and liquid barriers, and powder and spray barriers), by material (hyaluronic acid and cellulose-based barriers, synthetic polymer-based barriers, collagen-based barriers, and starch and polysaccharide-based barriers), by application (gynecological surgery, general and abdominal surgery, orthopedic and spine surgery, cardiovascular surgery, neurological surgery, urological surgery, and others), by end-user (hospitals, ambulatory surgical centers, specialty clinics, and others), and by geography (North America, Europe, Asia-Pacific, and the Rest of the World).

By Product Type

Dominant Subsegment: Film and Membrane Barriers.

The film and membrane barriers category is expected to dominate the market. The film and membrane barriers segment accounted for a 39% share of the adhesion barrier market in 2025. Film and membrane barriers, including Baxter's Seprafilm HA/CMC membrane, Johnson & Johnson MedTech's Interceed oxidized regenerated cellulose barrier, Integra LifeSciences' DuraGen Plus collagen matrix, and Biom'Up's Cova CARD cardiac film, are the leading product category because they provide a physical, mechanically stable barrier that is straightforward to place precisely over the surgical site during open procedures and because they benefit from the longest-established and most extensive clinical evidence base among adhesion barrier formats. The dominance of the segment reflects the breadth of established, widely distributed film products across abdominopelvic, neurological, and cardiac surgery, and the preference of surgeons for a barrier that remains in place without migration during open laparotomy and sternotomy procedures. While gel, solution, powder, and spray barriers are substantial and, in the case of gel and spray formats compatible with laparoscopic delivery, faster-growing categories, the clinical familiarity, precision of placement, and evidence depth of film and membrane barriers sustain the leadership of the segment across the forecast period.

By Material

Dominant Subsegment: Hyaluronic Acid and Cellulose-Based Barriers.

The hyaluronic acid and cellulose-based barriers category is expected to dominate the market. The segment accounted for a 44% share of the adhesion barrier market in 2025. Hyaluronic acid and cellulose-based barriers, including Baxter's Seprafilm and Sepraspray HA/CMC products, Johnson & Johnson MedTech's Interceed and Intercoat oxidized regenerated cellulose barriers, and Anika Therapeutics' Hyalobarrier hyaluronic acid gel distributed by Nordic Pharma, are the leading material category because hyaluronic acid and cellulose polymers are naturally resorbable, biocompatible, and supported by the deepest body of comparative clinical evidence among adhesion barrier materials. The dominance of the segment reflects the multi-decade commercial history and regulatory approval breadth of HA/CMC and oxidized regenerated cellulose technologies across the United States, Europe, and Asia. While synthetic polymer-based barriers such as Fziomed's dual-polymer CMC-PEO gels and Baxter's icodextrin-based Adept solution, collagen-based barriers, and starch-based barriers such as PlantTec Medical's 4DryField PH are significant and, in several cases, faster-growing categories, the evidence depth and regulatory maturity of hyaluronic acid and cellulose-based barriers sustain the leadership of the segment across the forecast period.

Adhesion Barrier Market Region Analysis

Dominant Region: North America

North America accounted for a 41% share of the global adhesion barrier market in 2025, representing the highest regional market share globally. The leadership of the region reflects the concentration of leading manufacturers including Baxter, Fziomed, Integra LifeSciences, and Johnson & Johnson MedTech, the high volume of abdominal, pelvic, and spine surgery, advanced reimbursement and hospital purchasing infrastructure, and the depth of FDA premarket approval and de novo authorization activity, exemplified by Fziomed's November 2025 FDA authorization of Oxiplex gel for lumbar spine surgery. The United States is the largest national market, supported by the concentration of adhesion barrier manufacturers, comprehensive hospital distribution networks, and growing surgeon awareness of adhesion-related morbidity and cost. The concentration of vendors, regulatory leadership, and surgical volume reinforce the position of North America as the largest regional market across the forecast period.

Fastest Growing Region: Asia-Pacific

Asia-Pacific is projected to register the fastest compound annual growth rate through 2034. The region is expanding and modernizing its surgical infrastructure, increasing the volume of gynecological, abdominal, and spine surgery, and adopting adhesion barrier products from a growing base. China, Japan, and India are the principal national markets, supported by the construction and modernization of hospitals, the expansion of laparoscopic and minimally invasive surgical capacity, and the presence of Baxter's Seprafilm, which maintains commercial distribution in Japan, China, and South Korea. As hospitals build surgical capacity and as awareness of adhesion-related complications increases, the region increases its adoption of adhesion barrier products from a growing base, positioning Asia-Pacific as the fastest-growing regional market.

Regional Commentary

North America

North America leads the market, supported by the concentration of leading vendors, high surgical volume, and advanced regulatory and reimbursement infrastructure. The United States dominates the region through its concentration of manufacturers and hospital distribution networks and through continued FDA authorization of new indications.

Europe

Europe is a substantial market shaped by CE marking pathways, established reimbursement for surgical adjuncts, and the presence of vendors including Baxter, Johnson & Johnson MedTech, PlantTec Medical, Biom'Up, and Nordic Pharma. Germany, the United Kingdom, France, Italy, and Spain are the principal national markets, and PlantTec Medical's starch-based 4DryField PH platform is anchored in the region.

Asia-Pacific

Asia-Pacific is the fastest-growing region, driven by hospital modernization, the expansion of laparoscopic and minimally invasive surgical capacity, and the growth of gynecological, abdominal, and spine surgery volumes across China, Japan, and India.

Rest of World

The Rest of World, spanning Latin America, the Middle East, and Africa, represents an emerging opportunity as surgical infrastructure expands, though adoption varies by market and remains concentrated in leading private and academic hospitals.

Adhesion Barrier Market Competitive Landscape

The global adhesion barrier market is classified as Moderately Consolidated. A group of established medical technology companies holds a substantial share of the market through comprehensive surgical adjunct portfolios and long-standing hospital relationships, while specialist vendors compete on differentiated single-technology platforms across gel, spray, and starch-based formats. Competition centers on the breadth of the product portfolio across film, gel, solution, and powder formats, clinical evidence and regulatory authorization for specific surgical indications, compatibility with laparoscopic and minimally invasive delivery, and price. The competitive landscape is evaluated across the following dimensions:

  • Market concentration: Moderately consolidated, with Baxter and Johnson & Johnson MedTech holding a substantial share through their film, solution, and cellulose barrier portfolios, alongside specialist vendors including Fziomed, Integra LifeSciences, Anika Therapeutics, PlantTec Medical, Biom'Up, MAST Biosurgery, Nordic Pharma, and Actamax Surgical Materials.
  • Leading players: Baxter leads with its Seprafilm, Adept, and Coseal portfolio; Johnson & Johnson MedTech leads in oxidized regenerated cellulose with Interceed and Intercoat; Fziomed leads in dual-polymer gel and spray barriers with Oxiplex and SprayShield; and Integra LifeSciences leads in collagen-based dural adhesion barriers with DuraGen Plus.
  • Geographic reach: Baxter and Johnson & Johnson MedTech operate global commercial and regulatory organizations, while specialist vendors including PlantTec Medical, Biom'Up, and Nordic Pharma maintain more concentrated footprints centered on Europe.
  • Product portfolio strength: Competitive advantage rests on the breadth across film, gel, solution, and powder and spray formats, and on the range of surgical specialties addressed, from gynecological and abdominal surgery to cardiovascular and neurological surgery.
  • Pipeline strength: Development is concentrated in laparoscopic-compatible gel and spray delivery, multifunctional hemostasis and adhesion prevention products, and expanded indications such as Fziomed's 2025 authorization for lumbar spine pain reduction.
  • Strategic partnerships: Collaboration spans distribution partnerships, exemplified by Nordic Pharma's distribution of Anika Therapeutics' Hyalobarrier across Europe, and clinical research collaborations with academic surgical centers.
  • M&A activity: Consolidation has shaped the field, exemplified by Baxter's 2020 acquisition of the Seprafilm product family from Sanofi for USD 350 million and continued portfolio bolt-on activity among diversified surgical technology companies.
  • Innovation focus: Innovation is concentrated in laparoscopic and minimally invasive-compatible delivery formats, multifunctional hemostasis and adhesion prevention products, and expanded procedure-specific indications supported by new clinical evidence.
  • Regulatory standing: FDA premarket approval and de novo classification, CE marking, and alignment with surgical society guidance are decisive competitive credentials, with Fziomed's 2025 FDA authorization of Oxiplex for lumbar spine pain reduction representing a notable recent regulatory milestone.

Adhesion Barrier Market Recent Developmental Activities

  • In November 2025, Fziomed initiated commercialization in the United States of Oxiplex gel following FDA marketing authorization for reducing postoperative leg pain and neurological symptoms in adult patients undergoing lumbar spine procedures. Strategic significance: the authorization was the first FDA authorization specifically for this indication and broadened Fziomed's addressable market into spine surgery pain reduction.
  • In 2020, Baxter completed its acquisition of the Seprafilm adhesion barrier product family and related assets from Sanofi for USD 350 million. Strategic significance: the acquisition brought a leading, globally distributed HA/CMC adhesion barrier franchise into Baxter's advanced surgery portfolio alongside its hemostat and sealant business.

Adhesion Barrier Market Segmentation

Adhesion Barrier Market Assessment by Product Type

  • Film and Membrane Barriers
  • Gel Barriers
  • Solution and Liquid Barriers
  • Powder and Spray Barriers

Adhesion Barrier Market Assessment by Material

  • Hyaluronic Acid and Cellulose-Based Barriers
  • Synthetic Polymer-Based Barriers
  • Collagen-Based Barriers
  • Starch and Polysaccharide-Based Barriers

Adhesion Barrier Market Assessment by Application

  • Gynecological Surgery
  • General and Abdominal Surgery
  • Orthopedic and Spine Surgery
  • Cardiovascular Surgery
  • Neurological Surgery
  • Urological Surgery
  • Others

Adhesion Barrier Market Assessment by End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Others

Adhesion Barrier Market Assessment by Geography

  • North America
  • United States Adhesion Barrier Market Size in USD million (2023-2034)
  • Canada Adhesion Barrier Market Size in USD million (2023-2034)
  • Mexico Adhesion Barrier Market Size in USD million (2023-2034)
  • Europe
  • Germany Adhesion Barrier Market Size in USD million (2023-2034)
  • United Kingdom Adhesion Barrier Market Size in USD million (2023-2034)
  • France Adhesion Barrier Market Size in USD million (2023-2034)
  • Italy Adhesion Barrier Market Size in USD million (2023-2034)
  • Spain Adhesion Barrier Market Size in USD million (2023-2034)
  • Rest of Europe Adhesion Barrier Market Size in USD million (2023-2034)
  • Asia-Pacific
  • China Adhesion Barrier Market Size in USD million (2023-2034)
  • Japan Adhesion Barrier Market Size in USD million (2023-2034)
  • India Adhesion Barrier Market Size in USD million (2023-2034)
  • Australia Adhesion Barrier Market Size in USD million (2023-2034)
  • South Korea Adhesion Barrier Market Size in USD million (2023-2034)
  • Rest of Asia-Pacific Adhesion Barrier Market Size in USD million (2023-2034)
  • Rest of the World
  • Middle East Adhesion Barrier Market Size in USD million (2023-2034)
  • Africa Adhesion Barrier Market Size in USD million (2023-2034)
  • South America Adhesion Barrier Market Size in USD million (2023-2034)

Key Takeaways from the Adhesion Barrier Market Report Study

  • Market size analysis for the current adhesion barrier market size (2025), and market forecast for 9 years (2026 to 2034).
  • Top key product and technology developments, mergers, acquisitions, partnerships, and joint ventures that happened over the last 3 years.
  • Key companies dominating the global adhesion barrier market.
  • Various opportunities available for competitors in the adhesion barrier market space.
  • What are the top-performing segments in 2025? How will these segments perform in 2034?
  • Which are the top-performing regions and countries in the current adhesion barrier market scenario?
  • Which are the regions and countries where companies should concentrate their opportunities for adhesion barrier market growth in the future?

Target audience who can benefit from this adhesion barrier market report study

  • Adhesion barrier and surgical device providers
  • Research organizations and consulting companies
  • Surgical, gynecological, and related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in adhesion barrier devices
  • Various end-users who want to know more about the adhesion barrier market and the latest technological developments in the adhesion barrier market.

Frequently Asked Questions:

Q1. At what rate is the adhesion barrier market expected to grow?

The global adhesion barrier market is projected to grow at a compound annual growth rate of 6.9% during the forecast period from 2026 to 2034.

Q2. What is the current and projected size of the adhesion barrier market?

The global adhesion barrier market was valued at USD 1.1 billion in 2025 and is projected to reach USD 2.0 billion by 2034.

Q3. Which region dominates the adhesion barrier market?

North America dominated the adhesion barrier market with a 41% share in 2025, driven by the concentration of leading vendors, high surgical volume, and advanced regulatory and reimbursement infrastructure. Asia-Pacific is projected to record the fastest compound annual growth rate through 2034, driven by hospital modernization and rising surgical volumes across China, Japan, and India.

Q4. What are the key factors driving growth in the adhesion barrier market?

The principal drivers are the rising volume of abdominal, pelvic, gynecological, and spine surgeries; growing surgeon and patient awareness of adhesion-related morbidity and cost; the expanding clinical evidence base across hyaluronic acid, cellulose, synthetic polymer, and starch-based barrier technologies; the introduction of multifunctional hemostasis and adhesion prevention products; and the increasing adoption of minimally invasive surgical techniques.

Q5. Who are the major players in the adhesion barrier market?

The market is moderately consolidated and led by Baxter International Inc. and Medical Devices Business Services, Inc. (Johnson & Johnson MedTech), alongside Fziomed, Inc., Integra LifeSciences Holdings Corporation, Anika Therapeutics, Inc., PlantTec Medical GmbH, Biom'Up SA, MAST Biosurgery USA, Inc., Nordic Pharma, and Actamax Surgical Materials, LLC.

Table of Contents

1. Adhesion Barrier Market Introduction

  • 1.1. Scope of the Report
  • 1.2. Market Segmentation
  • 1.3. Market Overview at a Glance

2. Adhesion Barrier Market Executive Summary

  • 2.1. Key Highlights and Market Snapshot

3. Adhesion Barrier Market Key Factors Analysis

  • 3.1. Market Drivers
    • 3.1.1. Rising Volume of Abdominal, Pelvic, Gynecological, and Spine Surgeries
    • 3.1.2. Growing Awareness of Adhesion-Related Morbidity and Cost
    • 3.1.3. Expanding Clinical Evidence Base Across Barrier Technologies
    • 3.1.4. Multifunctional Hemostasis and Adhesion Prevention Products
  • 3.2. Market Restraints
    • 3.2.1. Inconsistent Clinical Evidence and Product-Specific Safety Considerations
    • 3.2.2. High Per-Unit Cost Relative to Standard Surgical Technique
    • 3.2.3. Limited Routine Integration into Standard Surgical Protocols
  • 3.3. Market Opportunities
    • 3.3.1. Laparoscopic and Minimally Invasive-Compatible Delivery
    • 3.3.2. Procedure-Specific Indication Expansion

4. Impact Analysis: AI, Geopolitical, Trade, and Economic Developments

5. Regulatory Analysis

  • 5.1. The United States
  • 5.2. Europe
  • 5.3. Japan
  • 5.4. China

6. Adhesion Barrier Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Adhesion Barrier Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Film and Membrane Barriers
    • 7.1.2. Gel Barriers
    • 7.1.3. Solution and Liquid Barriers
    • 7.1.4. Powder and Spray Barriers
  • 7.2. By Material
    • 7.2.1. Hyaluronic Acid and Cellulose-Based Barriers
    • 7.2.2. Synthetic Polymer-Based Barriers
    • 7.2.3. Collagen-Based Barriers
    • 7.2.4. Starch and Polysaccharide-Based Barriers
  • 7.3. By Application
    • 7.3.1. Gynecological Surgery
    • 7.3.2. General and Abdominal Surgery
    • 7.3.3. Orthopedic and Spine Surgery
    • 7.3.4. Cardiovascular Surgery
    • 7.3.5. Neurological Surgery
    • 7.3.6. Urological Surgery
    • 7.3.7. Others
  • 7.4. By End-User
    • 7.4.1. Hospitals
    • 7.4.2. Ambulatory Surgical Centers
    • 7.4.3. Specialty Clinics
    • 7.4.4. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. United States Adhesion Barrier Market Size in USD million (2023-2034)
      • 7.5.1.2. Canada Adhesion Barrier Market Size in USD million (2023-2034)
      • 7.5.1.3. Mexico Adhesion Barrier Market Size in USD million (2023-2034)
    • 7.5.2. Europe
      • 7.5.2.1. Germany Adhesion Barrier Market Size in USD million (2023-2034)
      • 7.5.2.2. United Kingdom Adhesion Barrier Market Size in USD million (2023-2034)
      • 7.5.2.3. France Adhesion Barrier Market Size in USD million (2023-2034)
      • 7.5.2.4. Italy Adhesion Barrier Market Size in USD million (2023-2034)
      • 7.5.2.5. Spain Adhesion Barrier Market Size in USD million (2023-2034)
      • 7.5.2.6. Rest of Europe Adhesion Barrier Market Size in USD million (2023-2034)
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. China Adhesion Barrier Market Size in USD million (2023-2034)
      • 7.5.3.2. Japan Adhesion Barrier Market Size in USD million (2023-2034)
      • 7.5.3.3. India Adhesion Barrier Market Size in USD million (2023-2034)
      • 7.5.3.4. Australia Adhesion Barrier Market Size in USD million (2023-2034)
      • 7.5.3.5. South Korea Adhesion Barrier Market Size in USD million (2023-2034)
      • 7.5.3.6. Rest of Asia-Pacific Adhesion Barrier Market Size in USD million (2023-2034)
    • 7.5.4. Rest of the World
      • 7.5.4.1. Middle East Adhesion Barrier Market Size in USD million (2023-2034)
      • 7.5.4.2. Africa Adhesion Barrier Market Size in USD million (2023-2034)
      • 7.5.4.3. South America Adhesion Barrier Market Size in USD million (2023-2034)

8. Adhesion Barrier Market Competitive Landscape

  • 8.1. Competitive Analysis
  • 8.2. Company Share Analysis (Premium Offering)

9. Adhesion Barrier Market Startup Funding and Investment Trends

10. Adhesion Barrier Market Company and Product Profiles

  • 10.1. Baxter International Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Company Snapshot
    • 10.1.3. Financial Overview
    • 10.1.4. Product Portfolio
    • 10.1.5. Strategic Initiatives / Entropy
  • 10.2. Fziomed, Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Company Snapshot
    • 10.2.3. Financial Overview
    • 10.2.4. Product Portfolio
    • 10.2.5. Strategic Initiatives / Entropy
  • 10.3. Integra LifeSciences Holdings Corporation
    • 10.3.1. Company Overview
    • 10.3.2. Company Snapshot
    • 10.3.3. Financial Overview
    • 10.3.4. Product Portfolio
    • 10.3.5. Strategic Initiatives / Entropy
  • 10.4. Medical Devices Business Services, Inc. (Johnson & Johnson MedTech)
    • 10.4.1. Company Overview
    • 10.4.2. Company Snapshot
    • 10.4.3. Financial Overview
    • 10.4.4. Product Portfolio
    • 10.4.5. Strategic Initiatives / Entropy
  • 10.5. Anika Therapeutics, Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Company Snapshot
    • 10.5.3. Financial Overview
    • 10.5.4. Product Portfolio
    • 10.5.5. Strategic Initiatives / Entropy
  • 10.6. PlantTec Medical GmbH
    • 10.6.1. Company Overview
    • 10.6.2. Company Snapshot
    • 10.6.3. Financial Overview
    • 10.6.4. Product Portfolio
    • 10.6.5. Strategic Initiatives / Entropy
  • 10.7. Biom'Up SA
    • 10.7.1. Company Overview
    • 10.7.2. Company Snapshot
    • 10.7.3. Financial Overview
    • 10.7.4. Product Portfolio
    • 10.7.5. Strategic Initiatives / Entropy
  • 10.8. MAST Biosurgery USA, Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Company Snapshot
    • 10.8.3. Financial Overview
    • 10.8.4. Product Portfolio
    • 10.8.5. Strategic Initiatives / Entropy
  • 10.9. Nordic Pharma
    • 10.9.1. Company Overview
    • 10.9.2. Company Snapshot
    • 10.9.3. Financial Overview
    • 10.9.4. Product Portfolio
    • 10.9.5. Strategic Initiatives / Entropy
  • 10.10. Actamax Surgical Materials, LLC
    • 10.10.1. Company Overview
    • 10.10.2. Company Snapshot
    • 10.10.3. Financial Overview
    • 10.10.4. Product Portfolio
    • 10.10.5. Strategic Initiatives / Entropy

For illustrative purposes, only the top 10 companies are listed in the Table of Contents. The report may include analysis and references to additional companies where relevant to the market assessment.

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer and Contact Us

List of Tables

  • Table 1: Global Adhesion Barrier Market Size in USD million (2023-2034)
  • Table 2: Global Adhesion Barrier Market Size by Product Type in USD million (2023-2034)
  • Table 3: Global Adhesion Barrier Market Size by Material in USD million (2023-2034)
  • Table 4: Global Adhesion Barrier Market Size by Application in USD million (2023-2034)
  • Table 5: Global Adhesion Barrier Market Size by End-User in USD million (2023-2034)
  • Table 6: Adhesion Barrier Market Size in North America in USD million (2023-2034)
  • Table 7: Adhesion Barrier Market Size in the United States in USD million (2023-2034)
  • Table 8: Adhesion Barrier Market Size in Canada in USD million (2023-2034)
  • Table 9: Adhesion Barrier Market Size in Mexico in USD million (2023-2034)
  • Table 10: Adhesion Barrier Market Size in Europe in USD million (2023-2034)
  • Table 11: Adhesion Barrier Market Size in Germany in USD million (2023-2034)
  • Table 12: Adhesion Barrier Market Size in the United Kingdom in USD million (2023-2034)
  • Table 13: Adhesion Barrier Market Size in France in USD million (2023-2034)
  • Table 14: Adhesion Barrier Market Size in Italy in USD million (2023-2034)
  • Table 15: Adhesion Barrier Market Size in Spain in USD million (2023-2034)
  • Table 16: Adhesion Barrier Market Size in the Rest of Europe in USD million (2023-2034)
  • Table 17: Adhesion Barrier Market Size in Asia-Pacific in USD million (2023-2034)
  • Table 18: Adhesion Barrier Market Size in China in USD million (2023-2034)
  • Table 19: Adhesion Barrier Market Size in Japan in USD million (2023-2034)
  • Table 20: Adhesion Barrier Market Size in India in USD million (2023-2034)
  • Table 21: Adhesion Barrier Market Size in Australia in USD million (2023-2034)
  • Table 22: Adhesion Barrier Market Size in South Korea in USD million (2023-2034)
  • Table 23: Adhesion Barrier Market Size in the Rest of Asia-Pacific in USD million (2023-2034)
  • Table 24: Adhesion Barrier Market Size in the Rest of the World in USD million (2023-2034)
  • Table 25: Adhesion Barrier Market Size in the Middle East in USD million (2023-2034)
  • Table 26: Adhesion Barrier Market Size in Africa in USD million (2023-2034)
  • Table 27: Adhesion Barrier Market Size in South America in USD million (2023-2034)
  • Table 28: Adhesion Barrier Market Competitive Landscape
  • Table 29: Adhesion Barrier Market Startup Funding and Investment Trends

List of Figures

  • Figure 1: Adhesion Barrier Market Drivers
  • Figure 2: Adhesion Barrier Market Restraints
  • Figure 3: Adhesion Barrier Market Opportunities
  • Figure 4: Impact Analysis: AI, Geopolitical, Trade, and Economic Developments
  • Figure 5: Regulatory Analysis of the Adhesion Barrier Market (the United States)
  • Figure 6: Regulatory Analysis of the Adhesion Barrier Market (Europe)
  • Figure 7: Regulatory Analysis of the Adhesion Barrier Market (Japan)
  • Figure 8: Regulatory Analysis of the Adhesion Barrier Market (China)
  • Figure 9: Porter's Five Forces Analysis of the Adhesion Barrier Market
  • Figure 10: Competitive Analysis of the Adhesion Barrier Market
  • Figure 11: Global Adhesion Barrier Market Size in USD million (2023-2034)
  • Figure 12: Global Adhesion Barrier Market Size by Product Type in USD million (2023-2034)
  • Figure 13: Global Adhesion Barrier Market Size by Material in USD million (2023-2034)
  • Figure 14: Global Adhesion Barrier Market Size by Application in USD million (2023-2034)
  • Figure 15: Global Adhesion Barrier Market Size by End-User in USD million (2023-2034)
  • Figure 16: Adhesion Barrier Market Size in North America in USD million (2023-2034)
  • Figure 17: Adhesion Barrier Market Size in the United States in USD million (2023-2034)
  • Figure 18: Adhesion Barrier Market Size in Canada in USD million (2023-2034)
  • Figure 19: Adhesion Barrier Market Size in Mexico in USD million (2023-2034)
  • Figure 20: Adhesion Barrier Market Size in Europe in USD million (2023-2034)
  • Figure 21: Adhesion Barrier Market Size in Germany in USD million (2023-2034)
  • Figure 22: Adhesion Barrier Market Size in the United Kingdom in USD million (2023-2034)
  • Figure 23: Adhesion Barrier Market Size in France in USD million (2023-2034)
  • Figure 24: Adhesion Barrier Market Size in Italy in USD million (2023-2034)
  • Figure 25: Adhesion Barrier Market Size in Spain in USD million (2023-2034)
  • Figure 26: Adhesion Barrier Market Size in the Rest of Europe in USD million (2023-2034)
  • Figure 27: Adhesion Barrier Market Size in Asia-Pacific in USD million (2023-2034)
  • Figure 28: Adhesion Barrier Market Size in China in USD million (2023-2034)
  • Figure 29: Adhesion Barrier Market Size in Japan in USD million (2023-2034)
  • Figure 30: Adhesion Barrier Market Size in India in USD million (2023-2034)
  • Figure 31: Adhesion Barrier Market Size in Australia in USD million (2023-2034)
  • Figure 32: Adhesion Barrier Market Size in South Korea in USD million (2023-2034)
  • Figure 33: Adhesion Barrier Market Size in the Rest of Asia-Pacific in USD million (2023-2034)
  • Figure 34: Adhesion Barrier Market Size in the Rest of the World in USD million (2023-2034)
  • Figure 35: Adhesion Barrier Market Size in the Middle East in USD million (2023-2034)
  • Figure 36: Adhesion Barrier Market Size in Africa in USD million (2023-2034)
  • Figure 37: Adhesion Barrier Market Size in South America in USD million (2023-2034)